Hisamitsu Drug Patent Portfolio
Hisamitsu owns 2 orange book drugs protected by 8 US patents Given below is the list of Hisamitsu's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11813364 | Patch | 22 Sep, 2033 | Active |
| US10022445 | Patch | 25 Jul, 2033 | Active |
| US10583121 | Patch | 25 Jul, 2033 | Active |
| US10814002 | Patch and method for producing the same | 25 Jul, 2033 | Active |
| US11123305 | Patch | 25 Jul, 2033 | Active |
| US9687474 | Patch | 25 Jul, 2033 | Active |
| US8809615 | Adhesive preparation | 03 Jan, 2030 | Active |
| US9233184 | Adhesive preparation | 01 Aug, 2027 | Active |
Latest Legal Activities on Hisamitsu's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hisamitsu.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Apr, 2024 | US10814002 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 14 Nov, 2023 | US11813364 |
| Patent eGrant Notification | 14 Nov, 2023 | US11813364 |
| Recordation of Patent eGrant | 14 Nov, 2023 | US11813364 |
|
Email Notification
Critical
| 14 Nov, 2023 | US11813364 |
| Mail Patent eGrant Notification | 14 Nov, 2023 | US11813364 |
|
Recordation of Patent Grant Mailed
Critical
| 14 Nov, 2023 | US11813364 |
|
Email Notification
Critical
| 27 Oct, 2023 | US11813364 |
|
Issue Notification Mailed
Critical
| 25 Oct, 2023 | US11813364 |
|
Application Is Considered Ready for Issue
Critical
| 11 Oct, 2023 | US11813364 |
| Dispatch to FDC | 11 Oct, 2023 | US11813364 |
|
Issue Fee Payment Verified
Critical
| 09 Oct, 2023 | US11813364 |
|
Issue Fee Payment Received
Critical
| 09 Oct, 2023 | US11813364 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 23 Aug, 2023 | US10583121 |
|
Electronic Review
Critical
| 27 Jul, 2023 | US11813364 |
Hisamitsu's Family Patents
Hisamitsu Drug List
Given below is the complete list of Hisamitsu's drugs and the patents protecting them.
1. Salonpas
Salonpas is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8809615 | Adhesive preparation |
03 Jan, 2030
(3 years from now)
| Active |
| US9233184 | Adhesive preparation |
01 Aug, 2027
(1 year, 6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Salonpas's drug page
2. Secuado
Secuado is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11813364 | Patch |
22 Sep, 2033
(7 years from now)
| Active |
| US10022445 | Patch |
25 Jul, 2033
(7 years from now)
| Active |
| US10583121 | Patch |
25 Jul, 2033
(7 years from now)
| Active |
| US10814002 | Patch and method for producing the same |
25 Jul, 2033
(7 years from now)
| Active |
| US11123305 | Patch |
25 Jul, 2033
(7 years from now)
| Active |
| US9687474 | Patch |
25 Jul, 2033
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Secuado's drug page